≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other specific arthropathies, wide

EFO MESH Endpoint Browser PheWeb

ARTHRO_SPEC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

None

0 out of 7 registries used, show all original rules.

0

4. Check minimum number of events

None

0

5. Include endpoints

829

6. Filter based on genotype QC (FinnGen only)

829

Control definitions (FinnGen only)

Control exclude
RHEUMA_ENDPOINTS

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 5330 2986 2302
Only index persons 4747 2725 2022
Unadjusted period prevalence (%)
Whole population 0.08 0.09 0.06
Only index persons 0.09 0.10 0.08
Median age at first event (years)
Whole population 47.23 48.64 45.31
Only index persons 45.54 47.24 43.26

-FinnGen-

Key figures

All Female Male
Number of individuals 829 516 313
Unadjusted period prevalence (%) 0.16 0.18 0.14
Median age at first event (years) 47.73 46.63 49.53

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
767
Matched controls
7671
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
159.8
323.0
330
36
P01BA02
ATC
hydroxychloroquine; oral
153.5
323.0
347
41
M12.3
ICD-10 Finland
Palindromic rheumatism
+∞
323.0
322
*
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
969.5
227.5
212
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
62.5
224.0
259
62
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
68.2
193.1
220
45
A07EC01
ATC
sulfasalazine; oral, rectal
56.4
190.8
225
56
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
58.5
165.7
194
44
M12.2
ICD-10 Finland
Villonodular synovitis (pigmented)
+∞
156.8
145
*
M17.1
ICD-10 Finland
Other primary gonarthrosis
24.5
141.4
206
113
M13.9
ICD-10 Finland
Arthritis, unspecified
39.6
123.0
156
49
7192F
ICD-9 Finland
Other and unspecified disorder of joint, Villonodular synovitis[SYNOVITIS VILLONODULARIS, POLVI]
+∞
121.1
113
*
L88
ICPC
Rheumatoid/seropositive arthritis
182.7
120.2
123
8
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
117.8
104.2
111
11
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
+∞
103.5
97
*
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
106.9
102.1
110
12
H02AB06
ATC
prednisolone; systemic
4.7
88.8
493
2110
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
461.0
84.8
83
*
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
877.3
82.0
79
*
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
12.1
78.2
150
151
L04AA13
ATC
leflunomide; oral
288.9
78.0
78
*
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
791.3
74.5
72
*
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
+∞
68.8
65
*
M25.5
ICD-10 Finland
Pain in joint
4.1
61.9
314
1112
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
36.5
61.5
79
24
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
12.9
60.6
111
99
1220
FHL
Arthroscopy
16.4
59.5
98
68
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
7.9
58.6
143
215
M12.8
ICD-10 Finland
Other specific arthropathies, not elsewhere classified
+∞
55.9
53
*
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
30.7
52.4
70
25
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
76.7
50.8
57
8
M01CB01
ATC
sodium aurothiomalate; parenteral
508.7
48.9
48
*
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
11.1
48.6
95
96
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
47.3
47.0
57
13
L04AB01
ATC
etanercept; parenteral
418.5
40.5
40
*
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
10.7
38.9
77
79
M12.0
ICD-10 Finland
Chronic postrheumatic arthropathy [Jaccoud]
+∞
38.9
37
*
NGR20
NOMESCO Finland
Intralesional or marginal excision of tumor of knee or lower leg
205.1
38.2
39
*
N02AX02
ATC
tramadol; systemic, rectal
2.7
35.6
356
1864
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
20.3
35.3
53
28
WX320
NOMESCO Finland
Spinalanesthesy
3.4
34.2
193
688
M01AH05
ATC
etoricoxib; oral
2.6
34.2
487
3087
71220
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Palindromic rheumatism
+∞
33.6
32
*
1222
FHL
Arthroscopy and synovial surgery
66.5
33.3
38
6
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
5.9
33.0
97
183
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
+∞
32.5
31
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.7
32.4
290
1402
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
5.3
32.2
104
220
M16.1
ICD-10 Finland
Other primary coxarthrosis
16.3
32.1
52
34
L15
ICPC
Knee symptom/complaint
3.4
30.7
171
599
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
111.2
29.9
32
*
M01AH01
ATC
celecoxib; oral (coxibs)
3.3
29.8
173
624
TNG10
NOMESCO Finland
Puncture of knee
155.9
28.8
30
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.4
28.3
375
2197
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
15.7
28.1
46
31
M01AE02
ATC
naproxen; oral, rectal
2.3
27.8
463
3026
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
4.5
27.3
103
256
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
+∞
27.2
26
*
M01CB03
ATC
auranofin; oral
+∞
27.2
26
*
ZX140
NOMESCO Finland
Intra articular
38.2
26.3
33
9
7151F
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]
+∞
26.2
25
*
H02AB07
ATC
prednisone; oral
3.4
25.9
140
473
L04AB04
ATC
adalimumab; parenteral
31.3
25.2
33
11
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
25.2
337
1951
A02BC02
ATC
pantoprazole; systemic
2.2
24.3
504
3545
M13.0
ICD-10 Finland
Polyarthritis, unspecified
+∞
24.1
23
*
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
+∞
24.1
23
*
NGF10
NOMESCO Finland
Total synovectomy of knee, open
+∞
24.1
23
*
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
89.7
23.8
26
*
N02AJ06
ATC
codeine and paracetamol; systemic
2.3
23.1
293
1634
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
123.7
22.7
24
*
M09AX01
ATC
hyaluronic acid; parenteral
9.2
22.4
47
54
M79.6
ICD-10 Finland
Pain in limb
2.3
22.0
278
1538
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
+∞
22.0
21
*
M17.3
ICD-10 Finland
Other post-traumatic gonarthrosis
39.9
21.8
27
7
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
226.2
21.7
22
*
M45
ICD-10 Finland
Ankylosing spondylitis
118.4
21.7
23
*
M01AC06
ATC
meloxicam; systemic, rectal
2.2
21.3
299
1731
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
17.2
21.1
33
20
NF1AA
NOMESCO Finland
Hip X-ray examination
5.9
21.0
60
109
B01AB05
ATC
enoxaparin; parenteral
2.4
21.0
218
1093
M12.5
ICD-10 Finland
Traumatic arthropathy
+∞
20.9
20
*
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
13.4
20.8
36
28
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
79.0
20.8
23
*
M01AX05
ATC
glucosamine; oral
2.9
20.1
137
539
N03AX16
ATC
pregabalin; oral
2.4
19.8
190
911
M35.7
ICD-10 Finland
Hypermobility syndrome
205.0
19.6
20
*
M01AH02
ATC
rofecoxib; oral
3.0
19.4
120
443
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
12.6
19.2
34
28
H02AB04
ATC
methylprednisolone; systemic
2.8
18.2
130
524
M35.3
ICD-10 Finland
Polymyalgia rheumatica
12.8
18.2
32
26
NH3EA
NOMESCO Finland
Feet X-ray examination with load
11.8
18.1
33
29
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
6.5
18.0
47
76
9311
FHL
Knee cleansing surgery (synovectomy, debridement)
68.3
17.8
20
*
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
16.1
17.6
28
18
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
6.5
17.5
46
75
B01AF01
ATC
rivaroxaban; oral
3.7
17.4
80
236
L90
ICPC
Osteoarthrosis of knee
6.9
17.3
43
65
M79.0
ICD-10 Finland
Rheumatism, unspecified
6.8
17.1
43
66
N02BE01
ATC
paracetamol; systemic, rectal
2.3
17.1
644
5361
S18
ICPC
Laceration/cut
2.0
17.0
303
1894
L40.5
ICD-10 Finland
Arthropathic psoriasis
64.8
16.8
19
*
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
35.9
16.7
21
6
NG1DG
NOMESCO Finland
Knee and lower leg very extensive MRI examination with high intensity magnet
92.1
16.6
18
*
NG1DA
NOMESCO Finland
X-ray of knees
28.2
16.6
22
8
M01AB55
ATC
diclofenac, combinations; oral
3.9
16.3
68
185
SPAT1202
SPAT
Intra-articular injection
8.2
16.2
36
46
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
25.1
16.1
22
9
M10.9
ICD-10 Finland
Gout, unspecified
6.9
16.0
40
61
M17.5
ICD-10 Finland
Other secondary gonarthrosis
61.3
15.8
18
*
WX111
NOMESCO Finland
Local infiltration anesthesia
61.3
15.8
18
*
L04AA17
ATC
[U] adalimumab; parenteral
+∞
15.7
15
*
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
+∞
15.7
15
*
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
4.7
15.6
53
118
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.1
15.3
91
324
M01AX17
ATC
nimesulide; oral
2.2
15.3
190
1016
M13.1
ICD-10 Finland
Monoarthritis, not elsewhere classified
29.3
15.2
20
7
ZXA05
NOMESCO Finland
Left side
2.2
15.0
186
991
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.8
14.9
64
179
L20
ICPC
Joint symptom/complaint NOS
6.3
14.7
39
65
L04AA11
ATC
[U] etanercept; parenteral
+∞
14.6
14
*
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
3.1
14.5
84
295
M07.3
ICD-10 Finland
Other psoriatic arthropathies
152.8
14.5
15
*
L04AX01
ATC
azathioprine; systemic
5.4
14.3
43
84
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.5
14.1
123
552
71239
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD
54.4
13.9
16
*
1221
FHL
Arthroscopy and meniscus surgery
7.4
13.7
32
45
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
76.5
13.6
15
*
L04AB06
ATC
golimumab; parenteral
76.5
13.6
15
*
J01DB01
ATC
cefalexin; oral
2.0
13.6
607
5059
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
+∞
13.6
13
*
7164A
ICD-9 Finland
Other and unspecified arthropathies, Transient arthropathy
+∞
13.6
13
*
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
34.7
13.5
17
5
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
21.6
13.4
19
9
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
8.8
13.3
28
33
M19.0
ICD-10 Finland
Primary arthrosis of other joints
3.1
13.3
75
258
1225
FHL
Arthroscopy and other therapeutic procedure
14.1
13.3
22
16
M23.8
ICD-10 Finland
Other internal derangements of knee
5.6
13.2
38
71
N02AA05
ATC
oxycodone; systemic
2.6
13.2
102
430
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.1
13.1
171
926
ZXA00
NOMESCO Finland
Right side
2.0
13.0
190
1074
M01AE03
ATC
ketoprofen; systemic, rectal
1.8
13.0
287
1890
M02AA07
ATC
piroxicam; topical
1.9
13.0
262
1672
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
3.1
13.0
74
257
L04AA01
ATC
[U] ciclosporin; systemic
11.8
12.9
23
20
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
71.1
12.6
14
*
NDG30
NOMESCO Finland
Fusion of wrist, total
+∞
12.5
12
*
71320
ICD-8 Finland
Osteo-arthritis and allied conditions, Traumatic spondylopathy
+∞
12.5
12
*
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
132.1
12.5
13
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.0
12.5
198
1158
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
3.4
12.3
61
192
M01AB05
ATC
diclofenac; systemic, rectal
1.7
12.2
491
3867
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.0
12.2
72
257
M16.9
ICD-10 Finland
Coxarthrosis, unspecified
5.9
12.1
33
58
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.6
12.0
54
158
M13.8
ICD-10 Finland
Other specified arthritis
16.7
11.7
18
11
XX9XE
NOMESCO Finland
Other ultrasound examination
30.5
11.7
15
5
M06
ICD-10 Finland
Other rheumatoid arthritis
66.0
11.6
13
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
11.6
274
1825
J01AA02
ATC
doxycycline; systemic
1.8
11.5
583
4883
7148X
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Other specified inflammatory polyarthropathies
121.8
11.5
12
*
N02AC04
ATC
dextropropoxyphene; oral
4.9
11.3
36
76
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
17.4
11.2
17
10
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
11.4
11.1
20
18
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
44.0
10.9
13
*
NG2AA
NOMESCO Finland
Patella X-ray examination
12.1
10.9
19
16
M02AA10
ATC
ketoprofen; topical
2.2
10.8
118
587
X59
ICD-10 Finland
Exposure to unspecified factor
2.1
10.7
130
680
NE1AA
NOMESCO Finland
Pelvis X-ray examination
4.0
10.6
42
110
A02BA02
ATC
ranitidine; systemic
2.0
10.6
143
779
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.3
10.4
53
171
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
3.6
10.4
46
133
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.3
10.4
102
483
SPAT1153
SPAT
Removal of sutures
1.8
10.4
218
1392
7177A
ICD-9 Finland
Internal derangement of knee, Chondromalacia of patella
9.0
10.3
21
24
A02BC03
ATC
lansoprazole; oral
1.8
10.3
207
1300
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.0
10.3
147
817
L03
ICPC
Low back symptom/complaint
1.9
10.2
169
991
J45.9
ICD-10 Finland
Asthma, unspecified
2.1
10.1
128
680
NDL52
NOMESCO Finland
Tenosynovectomy of hand
40.6
10.0
12
*
M10.0
ICD-10 Finland
Idiopathic gout
7.8
9.9
22
29
M79.7
ICD-10 Finland
Fibromyalgia
6.1
9.9
26
44
A46
ICD-10 Finland
Erysipelas
2.2
9.8
99
477
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
5.2
9.8
29
57
M25.4
ICD-10 Finland
Effusion of joint
13.6
9.7
16
12
M01AB01
ATC
indometacin; systemic, rectal
3.0
9.7
55
191
R06.0
ICD-10 Finland
Dyspnoea
1.9
9.6
171
1029
SPAT1263
SPAT
Sampling
1.7
9.5
289
2046
L28
ICPC
Limited function/disability (L)
2.2
9.5
99
484
L04AC07
ATC
tocilizumab; parenteral
+∞
9.4
9
*
J01FA10
ATC
azithromycin; systemic
1.6
9.3
413
3229
A02BC05
ATC
esomeprazole; systemic
1.6
9.3
287
2042
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
7.4
9.3
21
29
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.7
9.1
201
1294
NHM20
NOMESCO Finland
Excision of synovial ganglion of ankle or foot
9.2
9.1
18
20
WZA10
NOMESCO Finland
Long statement of health and health related matters
9.2
9.1
18
20
N03AX12
ATC
gabapentin; oral
2.1
9.0
104
532
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.9
8.9
55
201
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
8.9
128
712
J01FF01
ATC
clindamycin; systemic
1.8
8.9
189
1202
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.9
8.8
52
187
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
7.3
8.8
20
28
M04AA01
ATC
allopurinol; systemic
2.4
8.8
74
324
M03BX02
ATC
tizanidine; oral
1.6
8.6
449
3622
M05BA04
ATC
alendronic acid; oral
2.6
8.6
61
243
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
20.3
8.5
12
6
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.0
8.5
121
669
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
3.7
8.4
35
97
H02AB08
ATC
triamcinolone; systemic
91.0
8.4
9
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
8.4
243
1688
WX204
NOMESCO Finland
Axillary plexus blockaced
4.4
8.4
29
68
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.2
8.4
89
438
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
6.3
8.4
21
34
L04AA24
ATC
abatacept; parenteral
+∞
8.3
8
*
NGC00
NOMESCO Finland
Exchange of a loose part of prosthesis in knee joint
+∞
8.3
8
*
212
Kela drug reimbursment
Gout
+∞
8.3
8
*
9522
FHL
Synovectomy
+∞
8.3
8
*
NGC20
NOMESCO Finland
Secondary implantation of prosthesis in knee joint, normal prosthesis
+∞
8.3
8
*
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
5.9
8.3
22
38
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
4.9
8.3
26
55
L99
ICPC
Musculoskeletal disease other
7.2
8.3
19
27
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
8.3
147
880
SPAT1216
SPAT
Assessment of functional ability
2.1
8.2
99
515
L13
ICPC
Hip symptom/complaint
2.2
8.2
88
435
J01MA01
ATC
ofloxacin; systemic
2.4
8.1
70
310
R06AE07
ATC
cetirizine; oral
1.6
8.1
300
2216
NJ3NA
NOMESCO Finland
Measurement of difference in extremity lengty with X-ray
33.7
8.1
10
*
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
10.2
8.1
15
15
NFB40
NOMESCO Finland
Primary total prosthetic replacement of hip joint using hybrid technique
22.3
8.0
11
5
TQW40
NOMESCO Finland
Remowal of suture of skin
2.5
8.0
59
243
M15.8
ICD-10 Finland
Other polyarthrosis
7.3
8.0
18
25
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
7.9
226
1560
R52.9
ICD-10 Finland
Pain, unspecified
2.5
7.8
60
252
M01AH03
ATC
valdecoxib; oral
2.6
7.8
54
215
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.0
7.8
97
510
NHG24
NOMESCO Finland
Fusion of subtalar joint and between bones of ankle
45.4
7.7
9
*
B01AX06
ATC
[U] rivaroxaban; oral
45.4
7.7
9
*
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
6.3
7.6
19
31
R01BA52
ATC
pseudoephedrine, combinations; oral
1.6
7.6
223
1545
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
10.2
7.6
14
14
M01AE01
ATC
ibuprofen; systemic, rectal
1.8
7.5
656
5915
R03AK07
ATC
formoterol and budesonide; inhalant
1.8
7.5
142
865
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
7.5
353
2745
R51.80
ICD-10 Finland
Headache
2.0
7.4
97
520
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
7.4
151
940
N06AA09
ATC
amitriptyline; systemic
2.2
7.4
76
368
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
80.8
7.4
8
*
NF2AT
NOMESCO Finland
Injection to hip joint with ultrasound guidance
80.8
7.4
8
*
ZSN00
NOMESCO Finland
Procedure related to previous procedure classified in chapter N
13.5
7.4
12
9
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.5
7.4
57
239
J01FA06
ATC
roxithromycin; oral
1.6
7.4
283
2096
UJF32
NOMESCO Finland
Coloscopy
1.7
7.4
170
1103
9256
FHL
Synovectomy (knee 9311)
+∞
7.3
7
*
J01DA01
ATC
[U] cefalexin; systemic
1.5
7.3
437
3581
R03AC02
ATC
salbutamol; inhalant
1.5
7.2
364
2864
P01BA01
ATC
chloroquine; systemic
15.9
7.2
11
7
ZZH31
NOMESCO Finland
Bone allograft, small pieces
30.3
7.2
9
*
L12
ICPC
Hand/finger symptom/complaint
2.0
7.1
95
514
7170A
ICD-9 Finland
Internal derangement of knee, Old bucket handle tear of medial meniscus
6.7
7.1
17
26
Z50.1
ICD-10 Finland
Other physical therapy
2.9
7.1
41
145
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
5.7
7.1
19
34
M01AE11
ATC
tiaprofenic acid; oral, rectal
3.5
7.1
31
91
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.6
7.1
30
86
L17
ICPC
Foot/toe symptom/complaint
1.7
7.0
162
1050
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
6.9
183
1231
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.3
6.9
60
269
NGE10
NOMESCO Finland
Incision or suture of capsule of knee joint
13.9
6.9
11
8
C03CA01
ATC
furosemide; systemic
1.7
6.9
164
1070
NDU20
NOMESCO Finland
Removal of internal fixation device from wrist or hand
4.4
6.9
23
53
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
6.9
181
1214
M01AG01
ATC
mefenamic acid; oral
4.2
6.9
24
58
M65.9
ICD-10 Finland
Synovitis and tenosynovitis, unspecified
4.2
6.9
24
58
M01AC01
ATC
piroxicam; systemic, rectal
1.9
6.8
94
514
9243
FHL
Plastic of the patella and its tendons
11.1
6.8
12
11
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
6.2
6.8
17
28
M87.0
ICD-10 Finland
Idiopathic aseptic necrosis of bone
40.4
6.8
8
*
ND2BG
NOMESCO Finland
MRI of hand
40.4
6.8
8
*
M01AX01
ATC
nabumetone; oral
3.1
6.8
35
117
B01AX05
ATC
fondaparinux; parenteral
16.9
6.8
10
6
R52.2
ICD-10 Finland
Other chronic pain
3.7
6.6
27
75
D16.2
ICD-10 Finland
Benign neoplasm: Long bones of lower limb
12.4
6.6
11
9
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
6.6
192
1324
P01AB01
ATC
metronidazole; oral, rectal
1.5
6.6
273
2047
ZX120
NOMESCO Finland
Intravenous
2.2
6.6
66
319
G47.3
ICD-10 Finland
Sleep apnoea
1.7
6.5
137
860
E66.01
ICD-10 Finland
Obesity due to excess calories
2.4
6.5
53
231
M25.0
ICD-10 Finland
Haemarthrosis
10.1
6.5
12
12
M22.4
ICD-10 Finland
Chondromalacia patellae
3.9
6.5
25
66
L01
ICPC
Neck symptom/complaint
1.9
6.5
92
509
M54.5
ICD-10 Finland
Low back pain
1.6
6.5
211
1494
H02BX01
ATC
methylprednisolone, combinations; systemic
2.8
6.5
39
144
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
6.5
153
997
S83.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of knee
2.9
6.5
37
131
NCF20
NOMESCO Finland
Operation for osteochondritis of elbow joint, open
70.4
6.4
7
*
NF1DA
NOMESCO Finland
X-ray of hips
14.4
6.4
10
7
M48.0
ICD-10 Finland
Spinal stenosis
2.1
6.4
69
344
2402
FHL
External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)
6.6
6.4
15
23
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
3.7
6.3
26
73
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
2.3
6.3
56
254
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.9
6.3
90
500
9531
FHL
Arthrodesis of the hand joint
18.2
6.3
9
5
SPAT1229
SPAT
Assessment of need for aid
2.3
6.3
53
235
NGC60
NOMESCO Finland
Exchange or addition of patellar part
+∞
6.3
6
*
NGU00
NOMESCO Finland
Removal of partial prosthesis from knee joint, other or unspecified
+∞
6.3
6
*
293
Kela drug reimbursment
Baricitinib
+∞
6.3
6
*
NGC30
NOMESCO Finland
Secondary implantation of prosthesis in knee joint, special prosthesis
+∞
6.3
6
*
3006
Kela drug reimbursment
Baricitinib
+∞
6.3
6
*
L01CB
ATC
Podophyllotoxin derivatives
+∞
6.3
6
*
71250
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Chronic rheumatoid nodular fibrositis
+∞
6.3
6
*
7140B
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]
+∞
6.3
6
*
9503
FHL
Tendon or tendon sheath cleansing surgery (tenosynovectomy)
+∞
6.3
6
*
291
Kela drug reimbursment
Tofacitinib
+∞
6.3
6
*
7118F
ICD-9 Finland
Arthropathy associated with infections, Arthropathy associated with other infectious and parasitic diseases[ARTHRITIS POSTINFECTIOSA ALIA, POLVI]
+∞
6.3
6
*
L04AB05
ATC
certolizumab pegol; parenteral
+∞
6.3
6
*
TND10
NOMESCO Finland
Joint puncture, wrist or finger joint
+∞
6.3
6
*
NDG79
NOMESCO Finland
Other excision, reconstruction or fusion of joint of II-V finger
+∞
6.3
6
*
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
4.5
6.2
20
45
WX002
NOMESCO Finland
Sedation and analgesia
1.8
6.2
115
699
J01MA02
ATC
ciprofloxacin; systemic
1.5
6.1
251
1870
M67.4
ICD-10 Finland
Ganglion
2.4
6.1
47
200
M67.8
ICD-10 Finland
Other specified disorders of synovium and tendon
8.7
6.1
12
14
R05FB02
ATC
cough suppressants and expectorants
1.5
6.1
260
1954
1XC02
NOMESCO Finland
NA
10.1
6.0
11
11
J01MA12
ATC
levofloxacin; systemic
1.7
6.0
120
741
WX110
NOMESCO Finland
Local anesthesy
1.5
6.0
470
3988

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3021788) Differential panel - Synovial fluid
88
21
46.76
148.39
1.5
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
101
41
27.91
145.72
1.8
1.2
e6/l
15479.3
16171.1
0.03
76
31
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
106
53
22.79
140.91
1.6
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
310
862
5.15
107.41
1.5
1.2
u/ml
56.3
3.3
11.31
147
345
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
59
13
48.79
100.72
1.4
1.0
%
51.4
83.8
—
36
6
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
299
916
4.54
89.63
1.5
1.2
iu/ml
71.2
18.3
5.19
158
252
(3037522) Nuclear Ab [Titer] in Serum
235
668
4.51
76.39
1.5
1.2
titre
483.4
370.4
0.49
59
115
(3044941) Cell count panel - Synovial fluid
55
30
19.57
69.61
1.6
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
84
115
8.02
59.06
1.7
1.5
iu/ml
0.4
0.1
0.83
17
20
(3006315) Basophils [#/volume] in Blood
538
3024
3.22
56.57
9.9
4.7
e9/l
0.0
0.0
1.04
499
2596
(3001604) Monocytes [#/volume] in Blood
531
3012
3.12
53.97
10.0
4.6
e9/l
0.6
0.6
0.80
494
2583
(3013115) Eosinophils [#/volume] in Blood
544
3131
3.15
53.81
10.1
5.0
e9/l
0.2
0.2
0.14
506
2740
(3019198) Lymphocytes [#/volume] in Blood
539
3101
3.11
53.06
10.0
4.7
e9/l
1.9
2.0
0.97
499
2707
(3006504) Eosinophils/100 leukocytes in Blood
507
2835
3.03
52.27
10.3
4.7
%
2.9
2.9
0.01
490
2624
(3022096) Basophils/100 leukocytes in Blood
495
2747
2.99
51.47
10.4
4.7
%
0.7
0.7
2.06
479
2553
(3019069) Monocytes/100 leukocytes in Blood
505
2850
2.98
50.59
10.8
4.9
%
8.6
8.5
0.15
493
2658
(3018010) Neutrophils/100 leukocytes in Blood
507
2887
2.95
49.59
10.1
4.7
%
57.2
56.8
0.43
493
2696
(3002030) Lymphocytes/100 leukocytes in Blood
508
2933
2.89
47.74
10.6
4.8
%
28.2
28.3
0.05
493
2726
(3013650) Neutrophils [#/volume] in Blood by Automated count
582
3617
3.04
47.55
13.1
8.5
e9/l
3.9
4.0
0.77
538
3128
(3010144) Erythrocytes [#/volume] in Synovial fluid
35
18
20.26
45.18
1.5
1.1
e6/l
80491.2
40459.2
0.22
26
11
(3013707) Erythrocyte sedimentation rate by Westergren method
662
4622
3.15
40.02
8.4
2.9
mm/h
13.1
11.2
2.99
641
4232
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
73
138
5.70
37.45
1.7
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
365
1959
2.54
36.83
9.3
4.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
289
1456
2.51
32.58
3.0
2.3
umol/l
338.4
8591.3
7.35
262
1270
(3021440) Promyelocytes/100 leukocytes in Blood
128
446
3.21
28.87
4.6
3.8
%
0.1
0.1
0.05
39
123
(3017181) Myelocytes/100 leukocytes in Blood
133
475
3.14
28.77
4.6
3.7
%
1.0
0.9
0.15
41
136
(3037467) Urinalysis macro (dipstick) panel - Urine
591
4271
2.34
26.67
6.8
3.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
263
1374
2.34
26.42
6.3
3.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
37
50
7.70
26.06
1.4
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
120
431
3.09
25.58
4.4
3.7
%
0.3
0.7
1.35
31
98
(3025159) Blasts/100 leukocytes in Blood
117
417
3.10
25.26
4.7
3.9
%
0.0
0.9
0.53
33
103
(3005719) IgG [Mass/volume] in Serum or Plasma
114
406
3.10
24.62
3.3
2.8
g/l
10.1
10.5
0.40
103
368
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
647
4966
2.38
23.71
10.3
6.9
u/l
74.3
78.3
2.35
627
4653
(3019225) pH of Specimen
141
587
2.69
22.77
4.0
4.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
77
227
3.64
22.45
2.4
1.9
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
390
2512
2.04
22.07
2.6
2.2
nmol/l
77.8
76.5
0.37
361
2244
(3024263) Appearance of Synovial fluid
18
12
15.31
20.25
2.3
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
101
384
2.86
19.27
1.3
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
69
211
3.48
19.00
2.3
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
155
769
2.25
16.76
2.0
2.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
39
89
4.55
16.05
1.3
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
756
6568
2.72
15.68
20.6
11.9
mg/l
17.0
24.8
13.32
676
4990
(3035350) Ketones [Presence] in Urine by Test strip
420
3015
1.80
15.12
4.4
3.2
estimate
0.0
0.0
0.00
81
546
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
44
117
3.92
14.85
1.3
1.1
u/ml
2.6
4.1
—
5
16
(3017143) Hepatitis C virus Ab [Presence] in Serum
125
598
2.28
14.64
1.4
1.6
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
43
117
3.82
14.06
1.3
1.1
u/ml
4.6
2.4
—
6
10
(3028026) IgM [Mass/volume] in Serum or Plasma
81
328
2.63
13.61
2.0
1.8
g/l
1.1
1.4
1.20
71
301
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
416
3041
1.74
13.53
6.5
6.8
mmol/l
1.2
1.2
1.08
362
2560
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
84
355
2.52
12.92
4.0
3.2
kpa
5.2
5.2
0.41
76
341
(3022217) INR in Platelet poor plasma by Coagulation assay
136
713
2.09
12.58
20.1
21.3
inr
1.3
1.3
0.06
43
83
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
80
337
2.52
12.39
3.6
3.2
mmol/l
3.0
1.9
2.01
54
260
(3009343) pH of Capillary blood
82
350
2.49
12.35
3.7
3.2
ph
7.4
7.4
—
7
43
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
28
61
4.72
12.19
1.5
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
145
787
2.02
12.18
1.4
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
408
3029
1.68
12.04
5.8
4.4
estimate
0.0
0.0
0.50
82
552
(3008898) HLA-B27 [Presence]
51
173
3.08
11.88
1.1
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
409
3048
1.67
11.82
4.5
3.2
estimate
0.0
0.0
0.80
83
529
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
35
97
3.72
11.17
3.1
3.3
%
57.7
55.6
0.35
35
97
(3017732) Neutrophils [#/volume] in Blood
86
396
2.31
10.94
4.1
2.7
e9/l
3.8
4.1
0.50
65
320
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
263
1791
1.69
10.41
2.1
2.0
u/l
160.1
281.8
1.25
248
1696
(3030905) Polymorphonuclear cells [#/volume] in Blood
33
93
3.65
10.29
3.2
2.9
e9/l
4.0
4.1
0.11
33
93
(3013826) Glucose [Moles/volume] in Serum or Plasma
461
3628
1.61
10.10
4.4
4.8
mmol/l
6.6
6.7
0.72
439
3410
(3007164) IgA [Mass/volume] in Serum or Plasma
192
1213
1.76
9.91
1.6
1.5
g/l
2.4
2.4
0.03
125
742
(3044640) Blood type and Crossmatch panel - Blood
270
1880
1.65
9.68
2.5
2.2
—
—
—
0
0
(3013512) EKG study
258
1794
1.64
9.22
3.9
3.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
362
2740
1.57
9.01
4.3
3.8
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
60
258
2.43
8.90
1.7
2.3
u/l
35.5
40.2
0.95
55
237
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
715
6387
1.87
8.82
16.6
11.2
ml/min/173m2
82.8
82.8
0.01
642
5179
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
154
942
1.78
8.80
2.1
1.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
31
95
3.35
8.55
1.2
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
354
2691
1.55
8.50
2.3
2.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
288
2093
1.58
8.42
4.1
3.2
e6/l
113.8
107.2
0.03
207
1469
(3022313) Gas panel - Capillary blood
59
263
2.34
8.10
3.6
3.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
357
2746
1.53
7.97
5.5
6.0
mmol/l
1.2
1.2
0.87
329
2486
(3022948) Iron [Moles/volume] in Serum or Plasma
143
880
1.76
7.96
2.4
2.3
umol/l
12.0
14.2
3.05
135
816
(3008757) Leukocyte morphology finding [Identifier] in Blood
23
61
3.85
7.84
2.7
4.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
359
2773
1.52
7.82
14.2
8.0
e9/l
0.0
0.0
0.99
305
2231
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
205
1401
1.62
7.65
2.7
2.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
48
201
2.47
7.56
3.1
3.4
g/l
0.5
0.2
0.74
15
87
(3023368) Bacteria identified in Blood by Culture
223
1571
1.57
7.28
4.5
4.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
182
1225
1.62
7.19
3.0
2.3
e6/l
4.1
6.4
1.65
161
1069
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
129
795
1.74
7.11
4.1
4.1
%
31.6
32.1
0.25
112
528
(3004588) Protein electrophoresis panel - Serum or Plasma
69
347
2.08
7.07
1.9
3.0
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
227
1621
1.55
6.94
3.2
2.8
ng/l
1084.7
1185.1
0.21
195
1358
(3015377) Calcium [Moles/volume] in Serum or Plasma
286
2149
1.51
6.89
2.7
3.5
mmol/l
2.3
2.4
0.78
253
1906
(3015235) Bicarbonate [Moles/volume] in Capillary blood
37
145
2.62
6.69
3.6
2.6
mmol/l
25.7
25.2
0.24
28
132
(3024561) Albumin [Mass/volume] in Serum or Plasma
338
2643
1.47
6.62
4.7
4.6
g/l
35.4
35.9
0.74
318
2455
(3004789) Transferrin [Mass/volume] in Serum or Plasma
130
819
1.70
6.60
2.3
2.3
g/l
2.4
2.3
0.27
123
761
(40758558) Short blood count panel - Blood
215
1546
1.53
6.29
10.0
6.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
18
47
3.89
6.28
1.2
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
196
1383
1.55
6.25
1.7
1.6
mg/l
1.1
1.1
0.07
149
1043
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
120
755
1.69
6.11
2.4
2.3
%
20.6
24.3
2.44
107
642
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
36
147
2.51
6.02
1.3
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
69
375
1.92
5.72
2.6
2.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
27
98
2.81
5.67
3.5
2.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
92
551
1.75
5.59
1.9
2.1
nmol/l
321.8
389.9
2.83
85
513
(3007853) Bacteria identified in Skin by Aerobe culture
105
654
1.69
5.55
1.7
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
188
1349
1.51
5.48
4.6
3.2
—
—
—
0
0
(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay
5
0
+∞
5.21
1.4
0.0
mg/l
1.6
—
—
5
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
195
1423
1.48
5.21
2.5
1.9
mg/l
3.2
3.0
0.68
174
1184
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
492
4236
1.40
5.16
3.1
3.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
97
605
1.68
5.10
2.8
2.5
%
1.7
1.8
1.03
86
540
(3005570) Glucose [Moles/volume] in Urine
20
65
3.13
5.09
1.6
1.9
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
9
9
10.09
5.03
1.1
1.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
401
3350
1.38
4.97
6.3
6.5
umol/l
9.7
11.4
4.14
378
3193
(3023103) Potassium [Moles/volume] in Serum or Plasma
740
6905
1.67
4.97
18.2
14.2
mmol/l
4.0
4.0
0.77
722
6679
(3019550) Sodium [Moles/volume] in Serum or Plasma
738
6884
1.66
4.94
18.1
14.1
mmol/l
139.8
139.7
0.08
722
6669
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
672
6140
1.50
4.92
5.5
5.2
mmol/mol
38.7
39.6
1.95
639
5671
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
669
6110
1.49
4.88
5.2
4.6
mu/l
1.8
2.1
0.83
636
5596
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
300
2395
1.40
4.87
4.8
3.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
145
1013
1.52
4.75
1.5
1.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
224
1710
1.42
4.67
4.1
2.9
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
193
2.13
4.63
1.4
2.5
g/l
7.8
7.0
1.43
30
147
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
193
2.13
4.63
1.4
2.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
193
2.13
4.63
1.4
2.5
g/l
3.6
3.6
0.00
29
141
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
303
2445
1.38
4.54
2.0
1.9
pmol/l
94.4
95.7
0.17
182
1265
(3000494) Fungus identified in Specimen by Culture
110
731
1.58
4.50
1.3
1.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
110
742
1.56
4.22
2.3
2.2
ug/g
148.2
118.9
0.43
89
578
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
13
36
3.65
4.21
3.7
2.8
e6/l
664.2
752.4
—
5
16
(3032080) INR in Blood by Coagulation assay
295
2393
1.36
4.21
7.8
8.0
inr
1.2
1.2
0.01
73
704
(3019309) Folate [Moles/volume] in Red Blood Cells
146
1049
1.48
4.16
1.8
1.6
nmol/l
966.4
1197.6
2.89
116
792
(3003327) Ova and parasites identified in Stool by Light microscopy
38
190
2.05
4.04
1.4
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
288
2345
1.35
3.96
3.8
3.2
ng/l
22.3
51.5
1.13
204
1539
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
761
7220
1.66
3.93
17.4
8.9
u/l
25.3
26.4
1.32
749
6960
(40768797) Stomach Pathology biopsy report
123
865
1.50
3.89
1.3
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
71
441
1.67
3.82
2.1
2.8
e9/l
66.6
71.9
0.85
61
328
(3002582) Erythrocytes [#/volume] in Urine
228
1811
1.36
3.64
3.7
2.8
e6/l
27.0
64.4
2.11
191
1365
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
250
2014
1.35
3.64
2.8
2.4
u/l
57.0
55.8
0.17
240
1859
(3011412) CD3 cells [#/volume] in Blood
13
40
3.29
3.63
2.2
2.6
e9/l
1.1
1.1
—
7
22
(4024509)
14
46
3.08
3.54
1.9
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
120
857
1.47
3.52
1.3
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
9
17
5.34
3.51
1.0
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
42
230
1.87
3.48
1.6
1.7
g/l
1.4
1.4
0.08
36
195
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
15
52
2.92
3.48
1.9
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
15
52
2.92
3.48
1.9
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
15
52
2.92
3.48
1.9
1.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
178
1369
1.38
3.46
1.6
1.5
nmol/l
19.0
20.5
0.78
157
1159
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
28
133
2.14
3.43
1.3
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
46
262
1.80
3.38
1.3
1.2
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
12
37
3.28
3.35
1.2
1.4
—
64.0
—
0
6
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
148
1110
1.41
3.33
1.6
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
264
2173
1.32
3.26
4.1
2.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
205
1629
1.34
3.22
5.6
3.3
estimate
0.0
0.0
0.80
81
540
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
10
28
3.60
3.20
3.5
3.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
464
4119
1.29
3.19
5.2
3.9
e6/l
580.3
2943.0
—
7
63
(3001122) Ferritin [Mass/volume] in Serum or Plasma
318
2698
1.29
3.10
3.0
2.6
ug/l
101.0
129.5
2.48
304
2502
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
57
355
1.65
3.08
1.8
1.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
205
1641
1.33
3.05
3.7
2.7
e6/l
0.2
0.5
4.58
158
1211
(40761535) Cells panel - Urine sediment
72
477
1.56
3.02
4.8
3.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
83
570
1.51
2.97
1.5
1.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
75
504
1.54
2.96
1.1
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
50
304
1.69
2.96
2.2
2.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
9
6.70
2.87
1.0
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
180
1429
1.33
2.82
1.3
1.2
u/ml
0.6
1.7
2.07
43
382
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
10
31
3.25
2.78
2.1
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
10
31
3.25
2.78
2.1
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
10
31
3.25
2.78
2.1
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
10
31
3.25
2.78
2.0
1.9
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
25
125
2.03
2.73
2.8
4.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
42
252
1.70
2.64
2.5
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
27
141
1.95
2.63
2.2
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
168
1334
1.33
2.63
4.9
3.3
kg/l
1.0
1.0
0.57
39
181
(1761868) Lipid panel - Serum or Plasma
219
2618
0.78
2.60
2.7
2.7
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
7
7.18
2.55
1.8
3.7
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
33
3.06
2.53
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
33
3.06
2.53
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
33
3.06
2.53
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
33
3.06
2.53
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
33
3.06
2.53
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
33
3.06
2.53
1.0
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
70
481
1.50
2.52
3.2
2.5
ml/min/173m2
67.7
69.0
0.09
29
201
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
559
5155
1.26
2.48
4.5
3.9
pmol/l
14.9
14.7
0.92
530
4698
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
26
3.49
2.48
2.0
2.2
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
15
63
2.41
2.47
1.5
1.3
mu/l
54.6
54.0
0.01
15
58
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
14
57
2.48
2.46
2.4
1.9
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
7
17
4.14
2.36
1.9
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
17
78
2.20
2.32
2.2
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
17
79
2.18
2.26
2.2
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
17
79
2.18
2.26
2.2
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
17
80
2.15
2.20
2.2
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
30
173
1.76
2.19
1.5
1.5
ug/g
302.4
292.2
0.08
17
104
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
30
173
1.76
2.19
2.5
4.3
mg/l
26.9
50.2
0.78
25
147
(3034860) Kappa light chains.free [Mass/volume] in Serum
30
173
1.76
2.19
2.5
4.3
mg/l
30.1
50.7
2.12
25
145
(3007461) Platelets [#/volume] in Blood
778
7545
1.51
2.15
29.2
17.6
e9/l
262.0
252.8
3.46
770
7324
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
17
81
2.12
2.14
2.2
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
17
81
2.12
2.14
2.2
1.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
10
37
2.72
2.11
1.8
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
707
6755
1.32
2.10
4.5
4.2
mmol/l
4.7
4.8
0.46
673
6276
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
10
5.02
2.07
1.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
10
5.02
2.07
1.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
10
5.02
2.07
1.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
10
5.02
2.07
1.0
1.0
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
778
7551
1.49
2.07
29.2
17.6
e12/l
4.5
4.5
1.84
769
7308
(3010813) Leukocytes [#/volume] in Blood
778
7552
1.49
2.06
29.2
17.6
e9/l
6.9
6.6
3.77
766
7308
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
15
4.02
2.04
1.0
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
14
63
2.24
2.01
2.4
1.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
10
38
2.65
2.01
1.8
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
144
1162
1.29
2.00
3.2
3.5
ng/l
62.8
355.8
3.30
99
862
(3020682) Albumin/Creatinine [Ratio] in Urine
222
1888
1.24
1.98
3.7
3.8
mg/mmol
17.9
8.3
0.80
147
1163
(3022145) Colonoscopy Study observation
96
733
1.35
1.97
1.4
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
211
1786
1.24
1.97
3.1
3.0
mg/l
320.1
291.1
0.04
145
1094
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
8
27
2.98
1.94
1.0
2.7
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
20
106
1.91
1.92
3.3
2.1
g/l
127.5
130.1
0.21
14
81
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
27
158
1.73
1.91
1.2
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
56
392
1.46
1.89
3.2
3.3
pmol/l
4.2
4.5
1.77
50
348
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
24
136
1.79
1.89
1.6
1.8
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
22
3.20
1.88
1.9
2.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
11
46
2.41
1.85
1.2
1.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
678
6471
1.26
1.84
4.1
3.8
mmol/l
1.4
1.3
2.31
641
5955
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
715
6869
1.30
1.83
4.8
4.6
mmol/l
2.8
2.8
0.18
681
6345
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
5
12
4.19
1.82
1.0
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
85
648
1.35
1.78
1.6
1.9
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
19
102
1.88
1.77
1.3
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
17
88
1.95
1.76
1.1
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
700
6715
1.27
1.76
4.5
4.1
mmol/l
1.4
1.5
1.61
665
6198
(3006245) CD3-CD19+ cells/100 cells in Blood
5
13
3.86
1.71
3.8
2.8
%
3.6
10.2
—
5
13
(3018418) pH of Serum or Plasma
208
1783
1.22
1.71
3.9
3.9
ph
7.4
7.4
0.15
47
330
(3035637) Corticotropin [Mass/volume] in Plasma
14
68
2.08
1.71
1.4
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
18
97
1.87
1.67
1.8
2.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
6
19
3.17
1.66
1.0
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
29
181
1.62
1.65
3.2
2.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
44
303
1.48
1.64
3.7
3.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
140
1158
1.25
1.60
2.5
3.0
mmol/l
2.4
2.4
0.29
130
1029
(3019420) Tryptase [Mass/volume] in Serum or Plasma
8
32
2.51
1.60
1.9
1.8
ug/l
6.1
10.7
—
8
25
(3025941) Bacteria identified in Stool by Culture
46
322
1.45
1.59
1.2
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
61
450
1.38
1.58
2.6
2.8
ng/l
177.4
188.3
0.07
53
415
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
20
3.01
1.58
1.2
1.1
iu/ml
244.8
321.9
—
6
20
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
684
6564
1.24
1.58
4.6
4.2
mmol/l
5.9
5.9
0.00
643
6002
(36304419) Bacteria [Presence] in Urine
189
1619
1.22
1.56
3.7
2.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
34
502
0.66
1.56
1.2
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
207
1792
1.21
1.54
4.3
4.5
ug/l
2.1
2.5
0.69
192
1605
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
487
4538
1.18
1.53
3.7
2.9
u/l
53.0
48.7
0.51
458
4255
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
15
3.35
1.52
1.0
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
7
27
2.61
1.51
1.6
4.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
126
0.39
1.51
1.2
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
126
0.39
1.51
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
126
0.39
1.51
1.2
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
126
0.39
1.51
1.2
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
120
983
1.26
1.50
3.3
2.4
e6/l
0.8
1.2
0.78
75
527
(3020961) Endomysium IgA Ab [Titer] in Serum
42
293
1.46
1.49
1.1
1.1
—
166.6
—
0
7
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
22
132
1.68
1.47
1.7
1.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
218
1904
1.20
1.47
3.2
3.0
mmol/l
7.3
7.6
0.31
199
1610
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
38
2.38
1.46
1.0
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
38
2.38
1.46
1.0
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
16
3.14
1.44
2.6
3.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
153
1296
1.22
1.41
1.6
1.6
pmol/l
449.9
47201924.4
1.95
128
1072
(3000093) Morphology [Interpretation] in Blood Narrative
10
46
2.19
1.40
1.2
1.2
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
7
29
2.43
1.39
2.1
1.4
nmol/l
1.4
1.1
—
7
21
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
29
2.43
1.39
1.4
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
29
2.43
1.39
1.4
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
64
488
1.34
1.38
3.6
3.5
mmol/l
1.2
1.2
0.63
58
410
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
23
2.62
1.37
1.0
1.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
96
775
1.27
1.37
5.1
5.2
mmol/l
1.0
1.0
0.38
90
709
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
24
151
1.61
1.36
1.3
2.6
g/l
0.0
0.0
0.50
24
138
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
17
97
1.77
1.35
1.2
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
20
120
1.68
1.35
3.3
1.9
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
32
216
1.50
1.35
2.2
2.7
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
9
42
2.16
1.34
1.1
1.2
mg/l
53.7
31.6
—
9
33
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
59
448
1.34
1.31
2.4
3.8
ng/l
81.1
86.7
0.23
51
393
(3009542) Hematocrit [Volume Fraction] of Blood
596
6223
0.85
1.30
18.6
13.2
%
40.0
40.0
0.01
432
4600
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
24
2.51
1.30
2.7
2.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
24
2.51
1.30
2.7
2.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
24
2.51
1.30
2.5
2.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
25
161
1.57
1.30
1.1
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
18
2.79
1.28
2.2
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
11
55
2.01
1.27
1.4
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
21
130
1.63
1.27
2.0
1.4
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
9
44
2.06
1.27
1.3
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
56
426
1.34
1.24
1.9
1.6
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
19
2.64
1.21
1.0
1.6
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
8
37
2.17
1.21
1.3
1.3
—
60.0
—
0
6
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
37
2.17
1.21
1.4
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
37
2.17
1.21
1.4
1.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
238
2127
1.17
1.21
3.2
3.2
u/l
29.5
32.4
1.02
228
2027
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
53
687
0.76
1.18
1.5
1.8
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
25
166
1.52
1.16
1.3
1.4
u/l
7.9
11.2
0.49
14
135
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
20
2.51
1.15
1.0
1.8
—
—
—
0
0
(44790049)
12
65
1.86
1.14
1.3
1.5
—
—
—
0
0
(44806118)
12
65
1.86
1.14
1.3
1.5
—
—
—
0
0
(44790047)
12
65
1.86
1.14
1.3
1.5
—
—
—
0
0
(44790048)
12
65
1.86
1.14
1.3
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
12
65
1.86
1.14
1.6
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
532
5579
0.87
1.13
21.9
15.0
%
13.8
13.6
1.13
523
5434
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
114
0.44
1.13
1.2
1.4
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
22
143
1.55
1.12
1.3
2.6
g/l
0.0
0.0
0.00
22
131
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
25
168
1.50
1.11
1.5
2.6
g/l
0.6
1.7
1.01
25
151
(3012095) Magnesium [Moles/volume] in Serum or Plasma
120
1019
1.21
1.10
3.4
3.3
mmol/l
0.8
0.8
1.08
114
957
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
137
0.51
1.10
1.4
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
27
185
1.47
1.09
2.2
3.1
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
22
144
1.54
1.09
1.3
2.6
g/l
0.0
0.0
0.00
22
131
(40761511) CBC panel - Blood by Automated count
722
7027
1.21
1.08
16.5
11.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
18
113
1.61
1.06
2.0
1.8
—
—
—
0
0
(4035726)
72
583
1.26
1.04
1.5
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
22
2.28
1.03
2.0
1.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
13
75
1.75
1.03
1.2
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
83
684
1.24
1.03
2.8
4.5
ug/l
2.8
29.4
1.50
60
565
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
53
1.90
1.01
1.5
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
109
0.46
1.01
1.2
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
109
0.46
1.01
1.2
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
9
48
1.88
1.00
1.1
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
25
173
1.46
0.98
1.4
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
15
92
1.64
0.97
1.1
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
12
69
1.75
0.97
1.3
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
14
222
0.62
0.96
1.3
1.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
27
2.23
0.93
1.2
1.2
nmol/l
140.0
152.4
—
6
27
(3023410) Appearance of Cerebral spinal fluid
12
70
1.72
0.93
1.2
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
24
167
1.45
0.93
1.6
1.3
—
—
—
0
0
(4010399)
57
457
1.27
0.91
1.5
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
14
86
1.64
0.91
1.1
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
29
2.08
0.89
1.0
4.1
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
8
42
1.91
0.88
1.0
1.1
mg/l
199.1
228.0
—
8
36
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
27
195
1.40
0.87
1.1
1.1
u/ml
3.1
8.2
—
5
25
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
30
2.01
0.87
1.2
1.0
—
—
—
0
0
(3000492) Spirometry study
75
625
1.22
0.86
1.6
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
8
44
1.83
0.86
1.0
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
85
719
1.20
0.85
2.4
2.7
umol/l
8.5
9.1
0.06
74
627
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
45
1.79
0.84
1.0
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
37
477
0.77
0.84
1.2
1.2
iu/ml
71.1
131.9
—
10
189
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
43
337
1.29
0.83
1.0
1.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
59
716
0.81
0.82
1.4
1.7
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
6
32
1.88
0.82
1.2
1.1
u/l
16.0
9.9
—
6
27
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
32
1.88
0.82
1.0
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
136
1203
1.16
0.81
3.1
2.5
mosm/kgh2o
536.4
551.4
0.42
115
1013
(4146454)
10
58
1.73
0.80
1.9
2.5
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.4
—
31.3
—
0
24
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
33
1.82
0.79
2.0
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
44
350
1.27
0.77
1.7
1.5
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
37
288
1.30
0.76
3.2
3.2
mmol/l
24.7
25.3
0.63
37
280
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
6
34
1.77
0.76
1.2
1.1
u/l
15.7
13.5
—
6
28
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
13
83
1.58
0.75
1.2
1.3
nmol/l
0.4
0.6
0.89
13
78
(3014133) Dog dander IgE Ab [Units/volume] in Serum
13
83
1.58
0.75
1.1
1.0
u/ml
17.5
3.9
—
5
29
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
22
158
1.40
0.75
1.4
1.3
mg/l
784.4
487.1
0.54
22
151
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
24
2.09
0.74
2.6
4.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
5
25
2.01
0.72
3.8
2.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
108
0.55
0.72
1.5
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
13
84
1.56
0.72
3.3
2.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
76
1.59
0.72
1.3
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
78
667
1.19
0.71
1.7
1.8
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
9
58
1.56
0.70
1.8
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
58
1.56
0.70
6.8
2.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
71
606
1.19
0.67
1.2
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
91
0.55
0.67
1.0
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
5
28
1.79
0.66
1.0
1.3
mmol/l
5.5
6.6
—
5
28
(3044889) 12 lead EKG panel
446
4647
0.91
0.65
3.7
3.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
95
1.48
0.64
1.3
1.7
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
5
29
1.73
0.64
1.2
1.3
umol/l
39.0
26.6
—
5
29
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
29
1.73
0.64
1.0
1.4
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
29
1.73
0.64
1.2
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
29
1.73
0.64
4.2
1.9
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
68
583
1.18
0.62
2.1
2.3
u/l
41.5
35.9
0.22
59
492
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
18
130
1.39
0.61
1.6
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
51
1.57
0.60
1.3
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
17
122
1.40
0.60
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
17
122
1.40
0.60
1.4
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
11
72
1.53
0.59
1.0
1.3
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
8
53
1.51
0.58
1.0
1.0
mg/l
331.5
294.0
—
8
46
(3033799) Differential panel - Peritoneal fluid
0
23
0.00
0.58
0.0
2.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
15
106
1.42
0.58
3.2
2.4
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
6
35
1.72
0.57
1.2
1.1
u/l
81.7
72.0
—
6
30
(3023430) Cat dander IgE Ab [Units/volume] in Serum
12
81
1.49
0.57
1.1
1.0
u/ml
1.0
3.5
—
5
27
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
81
1.49
0.57
1.4
1.8
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
14
98
1.44
0.56
1.1
1.2
u/ml
1.6
5.2
—
5
26
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
73
1.51
0.56
1.4
1.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
165
1790
0.90
0.56
1.7
1.6
mmol/l
1.5
1.4
0.78
153
1501
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
10
65
1.55
0.55
1.2
1.3
—
12.4
—
0
20
(4027681)
6
37
1.63
0.55
1.0
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
10
148
0.67
0.55
1.1
1.5
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
12
82
1.47
0.54
1.3
1.3
nmol/l
—
0.7
—
0
7
(40767503) Oxygen content in Capillary blood by calculation
15
108
1.40
0.53
4.6
2.3
%
15.7
16.3
—
10
51
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
76
668
1.15
0.53
1.8
1.8
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
39
1.54
0.53
1.3
1.9
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
10
66
1.52
0.52
1.3
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
9
135
0.66
0.52
1.7
3.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
39
324
1.21
0.52
1.5
1.3
iu/l
22.4
33.8
1.68
33
276
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
65
1.39
0.50
2.2
2.9
pg
31.8
32.2
—
9
65
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
45
1.56
0.49
1.9
1.3
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
7
111
0.63
0.48
2.6
5.0
umol/l
287.7
375.4
—
7
99
(3003888) Timothy IgE Ab [Units/volume] in Serum
14
102
1.38
0.47
1.1
1.0
u/ml
2.3
4.2
—
7
46
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
12
85
1.42
0.47
1.2
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
39
460
0.84
0.46
1.5
1.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
77
1.43
0.45
2.5
2.5
—
—
—
0
0
(3010421) pH of Blood
19
147
1.30
0.45
3.4
4.0
ph
7.4
7.4
0.90
14
112
(3027456) Digoxin [Moles/volume] in Serum or Plasma
14
103
1.37
0.45
2.9
3.4
nmol/l
0.8
0.8
—
9
81
(1616796) Gas panel - Central venous blood
15
112
1.35
0.45
5.1
3.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
158
1469
1.09
0.44
3.8
4.0
%
22.2
21.6
0.17
76
662
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
29
239
1.22
0.43
1.6
1.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
16
122
1.32
0.42
1.1
1.6
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
5
32
1.57
0.42
1.6
1.0
u/l
99.4
94.2
—
5
24
(3019060) Gas panel - Arterial blood
43
370
1.17
0.41
4.1
6.8
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
33
1.52
0.41
8.4
2.8
u/l
158.6
199.5
—
5
33
(3002331) Protein [Mass/volume] in Peritoneal fluid
0
15
0.00
0.41
0.0
1.3
—
23.8
—
0
10
(3042733) HLA Ab [Presence] in Serum
0
15
0.00
0.41
0.0
3.7
—
—
—
0
0
(4211845)
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
17
0.00
0.40
0.0
2.1
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
2.4
—
1.9
—
0
9
(3035933) Granulocytes/100 leukocytes in Blood
0
17
0.00
0.40
0.0
2.9
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
19
150
1.27
0.40
2.6
2.3
ug/min
44.3
114.9
1.09
12
93
(3016018) Differential panel - Cerebral spinal fluid
8
60
1.34
0.40
1.0
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
60
1.34
0.40
3.9
4.0
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.4
—
1.9
—
0
18
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
66
589
1.13
0.40
2.9
3.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
84
761
1.12
0.40
7.9
6.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
61
1.31
0.39
1.1
2.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
35
1.43
0.39
9.0
6.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
166
1557
1.08
0.39
3.6
3.6
%
93.8
92.1
0.34
161
1521
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
28
233
1.21
0.39
1.5
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
16
124
1.30
0.39
1.2
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
72
648
1.12
0.38
6.8
9.6
mmol/l
0.4
1.2
0.77
56
507
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
80
1.38
0.38
1.5
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
191
1803
1.08
0.38
3.8
2.8
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
9
67
1.35
0.38
1.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
68
1.33
0.37
1.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
69
1.31
0.37
1.4
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
22
180
1.23
0.36
1.1
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
42
1.43
0.35
1.7
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
16
127
1.26
0.33
1.3
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
47
1.28
0.32
1.3
3.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
6
47
1.28
0.32
1.2
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
92
1.31
0.32
1.3
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
52
1.35
0.31
4.7
2.9
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
7
53
1.32
0.31
1.1
1.1
—
0.5
—
0
19
(4062490)
7
53
1.32
0.31
1.6
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
13
102
1.28
0.30
1.5
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
93
1.29
0.30
1.2
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
7
55
1.28
0.30
1.1
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
36
408
0.88
0.29
1.7
1.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
109
0.73
0.29
1.3
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
57
1.23
0.29
1.9
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
49
441
1.12
0.28
1.4
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
68
740
0.91
0.28
1.3
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
12
94
1.28
0.28
5.0
2.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
12
94
1.28
0.28
1.0
1.0
u/ml
0.3
4.1
—
5
24
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
62
1.29
0.28
1.0
1.9
—
—
—
0
0
(4268621)
8
64
1.25
0.27
2.0
2.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
58
530
1.10
0.26
4.8
3.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
12
95
1.27
0.26
1.8
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
73
0.68
0.26
1.2
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
73
1.24
0.25
1.1
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
24
207
1.16
0.25
1.3
1.3
miu/ml
195.1
247.2
0.37
13
102
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
37
333
1.12
0.22
1.7
1.9
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
92
0.76
0.22
3.1
2.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
93
0.75
0.22
1.4
1.1
—
—
—
0
0
(4306422)
7
94
0.74
0.22
1.0
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
94
0.74
0.22
1.7
1.7
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
27
305
0.88
0.22
2.1
1.7
mg/l
4.9
5.2
0.04
19
214
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
14
116
1.21
0.22
1.1
1.1
u/ml
1.3
2.6
—
6
41
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
29
325
0.89
0.21
5.1
9.3
mmol/l
25.7
25.0
0.45
29
320
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
11
0.00
0.21
0.0
3.8
—
0.6
—
0
11
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
12
98
1.23
0.21
4.2
2.8
u/ml
7.4
6.1
0.17
12
92
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.4
—
0.5
—
0
7
(3036048) Francisella tularensis Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
110
1157
0.94
0.21
1.5
1.4
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
11
89
1.24
0.21
1.0
1.0
g/l
1.6
1.5
0.56
11
83
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
14
0.00
0.20
0.0
1.3
—
0.6
—
0
9
(44813793)
6
53
1.13
0.18
1.2
1.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
29
321
0.90
0.18
12.2
13.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
59
1.19
0.18
1.1
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
62
1.13
0.17
1.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
18
205
0.88
0.17
3.7
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
19
167
1.14
0.17
2.6
3.0
u/ml
0.3
0.4
1.25
13
97
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
69
1.16
0.16
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
19
168
1.13
0.15
1.4
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
10
83
1.21
0.15
1.0
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
45
482
0.93
0.15
8.5
9.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
19
169
1.13
0.14
1.4
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
20
223
0.89
0.14
3.4
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
20
223
0.89
0.14
3.4
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
28
256
1.10
0.14
1.2
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
99
951
1.05
0.14
3.5
2.5
e6/l
2.9
2.8
0.03
54
493
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
12
103
1.17
0.13
1.1
1.0
u/ml
1.1
2.3
—
7
51
(3027008) Opiates [Presence] in Urine
20
222
0.90
0.13
3.4
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
20
221
0.90
0.13
1.5
1.5
—
—
—
0
0
(1002224) Polysomnography panel
29
313
0.92
0.12
1.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
19
172
1.11
0.11
1.7
1.8
iu/l
6.3
5.7
—
5
64
(4034850)
20
219
0.91
0.11
9.9
9.9
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
104
1073
0.96
0.10
3.1
2.8
ug/l
0.7
0.8
0.42
77
669
(3002032) Base excess in Venous blood by calculation
56
535
1.05
0.10
3.0
3.4
mmol/l
2.2
2.0
0.17
42
429
(3042111) Morphology [Interpretation] in Bone marrow Narrative
11
96
1.15
0.10
2.4
1.6
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
14
125
1.12
0.10
1.1
1.1
iu/ml
1.2
77.1
—
5
23
(1001926) Buprenorphine [Presence] in Urine by Screen method
15
166
0.90
0.10
4.1
1.8
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
5
46
1.09
0.09
1.0
1.0
ng/l
255.8
327.6
—
5
32
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
5
47
1.06
0.09
1.0
1.0
ng/l
34.4
50.9
—
5
32
(3020876) Protein [Mass/time] in 24 hour Urine
6
54
1.11
0.09
1.3
2.1
—
1.2
—
0
5
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
58
1.03
0.08
1.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
30
318
0.94
0.08
1.9
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
61
0.82
0.08
1.8
3.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
63
0.79
0.08
1.2
1.1
—
—
—
0
0
(4281824)
7
84
0.83
0.07
1.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
85
1.06
0.07
1.6
1.9
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
81
830
0.97
0.06
2.0
1.8
%
1.5
1.4
0.41
69
738
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
18
168
1.07
0.06
1.4
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
173
1751
0.98
0.05
1.4
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
19
200
0.95
0.04
1.5
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
12
129
0.93
0.03
1.5
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
23
240
0.96
0.03
1.8
1.8
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
12
112
1.07
0.03
1.2
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
12
112
1.07
0.03
1.2
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
14
133
1.05
0.01
4.1
3.5
mg/l
23.4
24.0
—
5
84
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
11
114
0.96
0.00
1.1
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
18
185
0.97
0.00
1.1
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
26
265
0.98
0.00
1.5
1.9
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
17
174
0.98
0.00
4.0
4.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
18
184
0.98
0.00
1.6
2.3
u/l
658.8
2767.1
—
9
72
(3011288) Drugs identified in Urine by Screen method
15
147
1.02
0.00
4.9
2.6
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
10
102
0.98
0.00
1.4
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
10
102
0.98
0.00
1.0
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
109
1.01
0.00
1.0
1.4
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
27
269
1.00
0.00
3.9
3.2
%
48.4
50.1
0.14
27
264
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.4
—
1.5
—
0
9
(40758292) HTLV I+II Ab panel - Serum
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
0
8
0.00
0.00
0.0
1.8
—
272.5
—
0
8
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
9
0.00
0.00
0.0
2.6
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
9
0.00
0.00
0.0
4.8
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
66
0.91
0.00
1.8
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
10.8
—
0
9
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
190.4
—
0
5
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
11.2
—
—
—
0
0
(4094501)
17
170
1.00
0.00
1.1
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
34.5
—
0
6
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
11.6
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
54
0.93
0.00
1.0
1.4
g/l
0.9
1.0
—
5
54
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020891) Body temperature
22
220
1.00
0.00
4.6
4.3
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
7
69
1.01
0.00
1.4
1.9
ug/l
72.3
21.0
—
7
69
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
5
0.00
0.00
0.0
4.2
—
7.5
—
0
5

Mortality – FinRegistry

↥

Association

Association between endpoint ARTHRO_SPEC and mortality.

Females

Parameter HR [95% CI] p-value
ARTHRO_SPEC 1.041 [0.88, 1.23] 0.631
Birth year 0.997 [0.99, 1.01] 0.483

During the follow-up period (1.1.1998 — 31.12.2019), 205 out of 1773 females with ARTHRO_SPEC died.

Males

Parameter HR [95% CI] p-value
ARTHRO_SPEC 1.271 [1.08, 1.5] 0.005
Birth year 0.989 [0.98, 1.0] 0.031

During the follow-up period (1.1.1998 — 31.12.2019), 220 out of 1252 males with ARTHRO_SPEC died.

Mortality risk

Mortality risk for people of age

years, who have ARTHRO_SPEC.

N-year risk Females Males
1 0.123% 0.28%
5 0.608% 1.685%
10 1.514% 4.008%
15 3.05% 7.209%
20 5.688% 12.403%

Relationships between endpoints

↥

Index endpoint: ARTHRO_SPEC – Other specific arthropathies, wide

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data